Heron Therapeutics is trading at $0.37, up 7.83% after-hours as the weak September jobs report eased rate-hike concerns.
- Reuters reported the 29,000 September payroll gain fueled a bounce in stocks and bonds; the S&P 500 and Nasdaq each gained more than 0.5%.
- No company-specific announcement for October 2 was identified; Heron Therapeutics’ release page lists August 10 as its latest release.